X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare JUBILANT LIFE SCIENCES with Fresenius Kabi Onco. - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs FRESENIUS KABI ONCO. - Comparison Results

FRESENIUS KABI ONCO. 
   Change

Fresenius Kabi Oncology is the erstwhile Dabur Pharma, which was incorporated in March 2003. The company is a leading player in oncology in India and the international markets. Fresenius Kabi Oncology operates in the regulated markets namely the US a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT LIFE SCIENCES FRESENIUS KABI ONCO. JUBILANT LIFE SCIENCES/
FRESENIUS KABI ONCO.
 
P/E (TTM) x 26.0 22.1 117.4% View Chart
P/BV x 5.3 3.1 171.3% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 JUBILANT LIFE SCIENCES   FRESENIUS KABI ONCO.
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-14
FRESENIUS KABI ONCO.
Mar-13
JUBILANT LIFE SCIENCES/
FRESENIUS KABI ONCO.
5-Yr Chart
Click to enlarge
High Rs187176 106.1%   
Low Rs6579 82.9%   
Sales per share (Unadj.) Rs364.337.7 966.8%  
Earnings per share (Unadj.) Rs6.85.1 134.4%  
Cash flow per share (Unadj.) Rs24.56.7 364.4%  
Dividends per share (Unadj.) Rs3.000-  
Dividend yield (eoy) %2.40-  
Book value per share (Unadj.) Rs164.942.5 387.6%  
Shares outstanding (eoy) m159.28158.23 100.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.33.4 10.2%   
Avg P/E ratio x18.425.0 73.6%  
P/CF ratio (eoy) x5.118.9 27.2%  
Price / Book Value ratio x0.83.0 25.5%  
Dividend payout %43.80-   
Avg Mkt Cap Rs m20,06120,135 99.6%   
No. of employees `0006.21.2 536.9%   
Total wages/salary Rs m11,052703 1,571.6%   
Avg. sales/employee Rs Th9,383.05,176.2 181.3%   
Avg. wages/employee Rs Th1,786.9610.4 292.7%   
Avg. net profit/employee Rs Th176.3699.6 25.2%   
INCOME DATA
Net Sales Rs m58,0345,963 973.2%  
Other income Rs m19118 1,058.9%   
Total revenues Rs m58,2245,981 973.5%   
Gross profit Rs m5,7861,430 404.6%  
Depreciation Rs m2,812258 1,090.2%   
Interest Rs m3,237-26 -12,450.8%   
Profit before tax Rs m-721,216 -5.9%   
Minority Interest Rs m-2860-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m2,145-68 -3,149.6%   
Tax Rs m696342 203.5%   
Profit after tax Rs m1,090806 135.3%  
Gross profit margin %10.024.0 41.6%  
Effective tax rate %-965.928.1 -3,432.8%   
Net profit margin %1.913.5 13.9%  
BALANCE SHEET DATA
Current assets Rs m29,2805,102 573.9%   
Current liabilities Rs m38,9122,385 1,631.2%   
Net working cap to sales %-16.645.6 -36.4%  
Current ratio x0.82.1 35.2%  
Inventory Days Days84150 56.2%  
Debtors Days Days51113 44.7%  
Net fixed assets Rs m55,7125,148 1,082.2%   
Share capital Rs m155158 97.7%   
"Free" reserves Rs m20,9686,556 319.8%   
Net worth Rs m26,2656,732 390.2%   
Long term debt Rs m17,169952 1,803.1%   
Total assets Rs m88,60610,388 853.0%  
Interest coverage x1.0-45.8 -2.1%   
Debt to equity ratio x0.70.1 462.1%  
Sales to assets ratio x0.70.6 114.1%   
Return on assets %4.97.5 65.1%  
Return on equity %4.212.0 34.7%  
Return on capital %11.614.6 79.2%  
Exports to sales %37.874.5 50.7%   
Imports to sales %16.524.8 66.5%   
Exports (fob) Rs m21,9334,441 493.9%   
Imports (cif) Rs m9,5671,477 647.6%   
Fx inflow Rs m22,0045,298 415.4%   
Fx outflow Rs m11,7491,772 663.0%   
Net fx Rs m10,2553,525 290.9%   
CASH FLOW
From Operations Rs m8,0261,274 629.9%  
From Investments Rs m-1,744-1,204 144.8%  
From Financial Activity Rs m-4,447-196 2,267.9%  
Net Cashflow Rs m1,834-126 -1,452.5%  

Share Holding

Indian Promoters % 45.6 0.0 -  
Foreign collaborators % 3.5 81.0 4.3%  
Indian inst/Mut Fund % 8.7 0.3 2,900.0%  
FIIs % 21.2 9.6 220.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.1 9.1 231.9%  
Shareholders   23,815 42,599 55.9%  
Pledged promoter(s) holding % 15.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT LIFE SCIENCES With:   TTK HEALTHCARE  ALEMBIC LTD  WYETH LTD  CADILA HEALTHCARE  SUVEN LIFE  

Compare JUBILANT LIFE SCIENCES With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Of Global Markets Hitting Record Highs and Top Stocks in Action During the Week(RoundUp)

Global stock markets ended the week on a positive note. Benchmark indices in US grew by 1% during the week. The Down Jones Industrial Average topped the 26,000.

Related Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Jan 19, 2018 (Close)

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES 5-YR ANALYSIS

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS